Clogged pipeline: Many Hong Kong IPO hopefuls near application expiration
Over 430 mainland Chinese companies are facing potential expiration of their Hong Kong IPO applications due to delays in approval from the China Securities Regulatory Commission (CSRC). More than 30 of these companies, including Qiandama and EVE Energy, have applications set to lapse within the next two weeks.

Briefing Summary
AI-generatedOver 430 mainland Chinese companies are facing potential expiration of their Hong Kong IPO applications due to delays in approval from the China Securities Regulatory Commission (CSRC). More than 30 of these companies, including Qiandama and EVE Energy, have applications set to lapse within the next two weeks. This backlog is the most severe since March 2023, when the CSRC's approval became a prerequisite for HKEX listing hearings. The current situation highlights a significant bottleneck in the IPO pipeline for Chinese firms seeking to list in Hong Kong.
Article analysis
Model · rule-basedKey claims
4 extractedThe backlog in the first half of the year was the most severe since March 31, 2023, when a mechanism was put in place that requires approval from the China Securities Regulatory Commission (CSRC) before HKEX can convene a listing hearing.
More than 430 companies were currently waiting in the initial public offering (IPO) pipeline, according to data from bourse operator Hong Kong Exchanges and Clearing (HKEX).
More than 30 companies faced the six-month expiration of their applications within the next two weeks.
A large number of mainland Chinese companies hoping to list shares on the Hong Kong stock exchange are anxiously waiting for a nod from the mainland securities regulator.